In Alport syndrome, disruption of the GBM caused by variants in COL4A3, COL4A4, or COL4A5 causes podocyte dysfunction and proteinuria, proliferation of Bowman’s epithelial cells, and progressive glomerulosclerosis. Here, COL4A3 is linked to Alport syndrome.